Stay updated with breaking news from Using Genetics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- HealthLynked Corp. (OTCQB: HLYK) will host a two-day global conference that explores promising anti-aging innovations, genomics and other...
Children's Hospital of Philadelphia President and CEO Releases Special Podcast Series - Breaking Through with Madeline Bell's "Pioneered at CHOP" series highlights stories about some of CHOP's amazing breakthroughs, told by the people who made them - News provided by Share this article Share this article PHILADELPHIA, May 5, 2021 /PRNewswire/ -- Doctors and scientists at Children's Hospital of Philadelphia (CHOP) are making breakthroughs that are transforming children's lives – and changing the world. In "Pioneered at CHOP," a five-episode special series of her popular podcast Breaking T...
Based on their analyses, the researchers are calling for prioritizing clinical trials of drugs targeting the proteins IFNAR2 and ACE2. The goal is to identify existing drugs, either FDA-approved or in clinical development for other conditions, that can be repurposed for the early management of COVID-19. Doing so, they say, will help keep people with the virus from being hospitalized. IFNAR2 is the target for approved drugs often used by patients with relapsing forms of the central nervous system disorder multiple sclerosis. The researchers believe the most promising ACE2 therapy against COVID...